drugset / Trial / NCT02268435
Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to determine the recommended dose of combination of dovitinib and imatinib in phase I study.
Timeline
- Start
- 2015-03
- Primary completion
- 2016-08
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dovitinib | Small molecule | — | — |
| Subject | Imatinib | Small molecule | — | — |